Axogen, Inc. (AXGN) Current Ratio
- Current ratio · latest quarter: Value 6.60×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 6.60× | Current assets / current liabilities. $200.38M ÷ $30.37M ≈ 6.60× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 200.38M USD | Assets, Current |
| Current obligations | 30.37M USD | Liabilities, Current |
| Cash and equivalents | 94.57M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 34.13M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 47.31M USD | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $200.38M | $30.37M | $94.57M | (m) | $34.13M | $47.31M | (m) | (m) | 6.60× |
| 2026-03-31 | $184.71M | $26.01M | $82.65M | (m) | $28.31M | $46.07M | (m) | (m) | 7.10× |
| 2025-12-31 | $120.42M | $23.56M | $35.55M | (m) | $26.17M | $42.37M | (m) | (m) | 5.11× |
| 2025-09-30 | $114.46M | $28.01M | $23.90M | (m) | $30.77M | $40.58M | (m) | (m) | 4.09× |
| 2025-06-30 | $103.42M | $24.98M | $20.04M | (m) | $28.03M | $36.77M | (m) | (m) | 4.14× |
| 2025-03-31 | $93.07M | $21.75M | $18.10M | (m) | $26.30M | $35.50M | (m) | (m) | 4.28× |
| 2024-12-31 | $99.22M | $30.61M | $27.55M | (m) | $24.11M | $33.18M | $8.01M | (m) | 3.24× |
| 2024-09-30 | $86.25M | $23.03M | $18.66M | (m) | $24.63M | $29.36M | (m) | (m) | 3.74× |
| 2024-06-30 | $82.26M | $23.41M | $19.19M | (m) | $25.15M | $28.02M | (m) | (m) | 3.51× |
| 2024-03-31 | $78.66M | $22.93M | $15.71M | (m) | $24.21M | $27.64M | (m) | (m) | 3.43× |
| 2023-12-31 | $88.00M | $30.43M | $31.02M | (m) | $25.15M | $23.02M | $11.77M | (m) | 2.89× |
| 2023-09-30 | $87.44M | $26.65M | $31.09M | (m) | $23.26M | $23.02M | (m) | (m) | 3.28× |
| 2023-06-30 | $86.18M | $23.93M | $23.22M | (m) | $21.57M | $21.24M | (m) | (m) | 3.60× |
| 2023-03-31 | $88.70M | $21.24M | $7.71M | (m) | $22.28M | $19.85M | (m) | (m) | 4.18× |
| 2022-12-31 | $98.08M | $23.75M | $15.28M | (m) | $22.19M | $18.91M | $8.96M | (m) | 4.13× |
| 2022-09-30 | $102.45M | $23.55M | $14.32M | (m) | $21.36M | $19.12M | (m) | (m) | 4.35× |
| 2022-06-30 | $106.78M | $23.60M | $11.82M | (m) | $20.37M | $19.22M | (m) | (m) | 4.52× |
| 2022-03-31 | $112.47M | $22.95M | $14.56M | (m) | $18.59M | $17.40M | (m) | (m) | 4.90× |
| 2021-12-31 | $127.05M | $24.29M | $32.76M | (m) | $18.16M | $16.69M | $5.92M | (m) | 5.23× |
| 2021-09-30 | $134.97M | $23.36M | $46.73M | (m) | $18.57M | $15.45M | $6.43M | (m) | 5.78× |
| 2021-06-30 | $141.79M | $21.63M | $53.08M | (m) | $18.18M | $13.41M | $6.72M | (m) | 6.56× |
| 2021-03-31 | $135.15M | $22.27M | $39.84M | (m) | $19.82M | $13.39M | $9.16M | (m) | 6.07× |
| 2020-12-31 | $145.25M | $22.83M | $48.77M | (m) | $17.62M | $12.53M | $4.60M | (m) | 6.36× |
| 2020-09-30 | $139.97M | $18.79M | $60.00M | (m) | $18.76M | $11.93M | $3.51M | $2.50M | 7.45× |
| 2020-06-30 | $140.23M | $14.02M | $75.32M | (m) | $14.05M | $12.84M | $3.89M | $1.55M | 10.00× |
| 2020-03-31 | $120.35M | $19.49M | $35.89M | (m) | $13.02M | $14.56M | $7.18M | $1.78M | 6.18× |
| 2019-12-31 | $135.02M | $20.88M | $35.72M | (m) | $16.94M | $13.86M | $8.26M | (m) | 6.47× |
| 2019-09-30 | $137.34M | $16.76M | $24.55M | (m) | $15.45M | $13.68M | $3.79M | $1.77M | 8.20× |
| 2019-06-30 | $141.29M | $16.23M | $24.88M | (m) | $16.29M | $13.59M | $5.68M | $1.83M | 8.70× |
| 2019-03-31 | $145.63M | $16.49M | $23.52M | (m) | $15.19M | $13.12M | $7.40M | $1.36M | 8.83× |
| 2018-12-31 | $150.95M | $13.04M | $24.29M | (m) | $15.32M | $11.98M | $4.52M | $28.00K | 11.57× |
| 2018-09-30 | $152.79M | $12.02M | $25.63M | (m) | $13.99M | $10.95M | $4.79M | $35.96K | 12.72× |
| 2018-06-30 | $156.91M | $9.86M | $133.56M | (m) | $12.36M | $9.68M | $4.16M | $39.03K | 15.92× |
| 2018-03-31 | $51.73M | $15.57M | $30.56M | (m) | $11.77M | $8.05M | $3.30M | $2.84M | 3.32× |
| 2017-12-31 | $55.74M | $13.72M | $36.51M | (m) | $11.06M | $7.32M | $3.24M | $735.00K | 4.06× |
| 2017-09-30 | $39.51M | $11.14M | $22.04M | (m) | $10.20M | $6.70M | $2.10M | $21.60K | 3.55× |
| 2017-06-30 | $40.18M | $10.95M | $23.87M | (m) | $9.42M | $6.30M | $3.05M | $24.95K | 3.67× |
| 2017-03-31 | $40.90M | $10.69M | $25.91M | (m) | $8.38M | $5.85M | $2.92M | $22.91K | 3.82× |
| 2016-12-31 | $44.04M | $11.08M | $30.01M | (m) | $8.05M | $5.46M | $3.61M | $20.90K | 3.97× |
| 2016-09-30 | $28.66M | $4.60M | $16.00M | (m) | $7.00M | $4.97M | $1.89M | (m) | 6.24× |
| 2016-06-30 | $29.75M | $3.92M | $18.27M | (m) | $6.07M | $4.79M | $1.86M | (m) | 7.58× |
| 2016-03-31 | $31.45M | $3.76M | $20.95M | (m) | $5.29M | $4.52M | $2.00M | (m) | 8.36× |
| 2015-12-31 | $35.05M | $3.71M | $25.91M | (m) | $4.78M | $3.93M | $2.11M | (m) | 9.45× |
| 2015-09-30 | $38.57M | $4.10M | $29.94M | (m) | $4.64M | $3.70M | $1.64M | (m) | 9.41× |
| 2015-06-30 | $23.24M | $3.42M | $15.62M | (m) | $3.84M | $3.54M | $1.84M | (m) | 6.79× |
| 2015-03-31 | $26.02M | $3.44M | $19.26M | (m) | $3.16M | $3.34M | $1.97M | (m) | 7.57× |
| 2014-12-31 | $14.41M | $2.45M | $8.22M | (m) | $2.87M | $3.21M | $1.16M | (m) | 5.89× |
| 2014-09-30 | $17.99M | $2.03M | $11.80M | (m) | $2.74M | $3.35M | (m) | (m) | 8.85× |
| 2014-06-30 | $20.25M | $2.25M | $14.17M | (m) | $2.53M | $3.41M | (m) | (m) | 8.99× |
| 2014-03-31 | $22.43M | $1.92M | $16.81M | (m) | $1.97M | $3.47M | (m) | (m) | 11.67× |
| 2013-12-31 | $25.66M | $2.10M | $20.07M | (m) | $1.89M | $3.40M | $1.18M | (m) | 12.23× |
| 2013-09-30 | $27.96M | $1.32M | $22.59M | (m) | $1.74M | $3.46M | (m) | (m) | 21.23× |
| 2013-06-30 | $13.81M | $1.59M | $8.69M | (m) | $1.42M | $3.58M | (m) | (m) | 8.70× |
| 2013-03-31 | $15.94M | $1.42M | $11.20M | (m) | $1.18M | $3.42M | (m) | (m) | 11.24× |
| 2012-12-31 | $18.30M | $1.48M | $13.91M | (m) | $1.05M | $3.15M | (m) | (m) | 12.36× |
| 2012-09-30 | $8.18M | $3.75M | $4.45M | (m) | $925.54K | $2.72M | (m) | $1.89M | 2.18× |
| 2012-06-30 | $8.21M | $3.11M | $4.64M | (m) | $862.23K | $2.47M | (m) | $1.40M | 2.64× |
| 2012-03-31 | $8.80M | $2.42M | $5.64M | (m) | $893.98K | $2.13M | (m) | $918.48K | 3.63× |
| 2011-12-31 | $10.88M | $2.02M | $8.19M | (m) | $797.65K | $1.76M | (m) | $434.73K | 5.39× |
| 2011-09-30 | $13.07M | $1.66M | $10.53M | (m) | $538.11K | $1.66M | (m) | $0.00 | 7.89× |
| 2011-06-30 | $9.59M | $611.57K | $7.84M | (m) | $19.11K | (m) | $207.36K | (m) | 15.69× |
| 2010-12-31 | $5.27M | $9.39M | $1.80M | (m) | $407.35K | $1.90M | (m) | $7.08M | 0.56× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |